Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)

Completed

Conditions studied: HIV/AIDS

In brief

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection (YAPHIV) as they transition into adulthood. A group of of perinatally exposed but uninfected young adults from a similar sociodemographic background and age distribution will be enrolled for comparison.

Key facts

Study ID
NCT02119702
Run by
Harvard School of Public Health (HSPH)
People needed
818
Starts
2014-04-01
Expected to finish
2025-05-31
Last updated by the study team
2025-06-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.